Verma IM and Somia N. Nature 389: 239-242., 1997.* |
Crystal RG. Science 270:404-410., 1995.* |
Rojanasakul Y. Advanced Drug Delivery Reviews 18:115-131, 1996.* |
Sherman MI. Annals of NY Acad. Sci. 616:201-204, 1990.* |
Holt J. Mol Med Today 2:184-185, 1996.* |
Maemura et al (The Journal of Biological Chemistry 274:31565-31570, 1999.* |
Ema et al. (1997) “A Novel bHLH-PAS Factor With Close Sequence Similarity To Hypoxia-Inducible Factor 1αRegulats THe VEGF Expression And is Potentially Involved in Lung and Vascular Development”, Proc. Natl. Acad. Sci. USA, vol. 94, pp. 4273-4278. |
Luo et al. (1997) “Molecular Characterization of The Murine Hif-1α Locus”, Gene Expression, vol. 6, pp. 287-299. |
Luo et al., “Molecular Characterization of Murine Hif-1a Locus”, Gene Expression, vol. 6, pp. 287-299, 1997. |
Scott et al., “Role of the Hypoxia Sensing System, Acidity and Reproduction Hormones . . . ”, Int. J. Cancer, 75, 706-712 (1998). |
Tian H. et al., “A Transcription Factor Selectively Expressed in Endothelial Cells”, Genes Dev. 11 (1), 72-82 (1997) Accession No. U91884. |
Thompson et al., “Clustal W: improving the sensitivity of progressive multiple sequence alignment through sequence . . . ”, Nucleic Acids Research, 1994, vol. 22, No. 22 4673-4680. |
Wang et al., “Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS . . . ”, Proc. Natl. Acad Sci. USA vol. 92, pp. 5510-5514, Jun. 1995. |
Melani et al., “Inhibition of Proliferation by c-myb Antisense Oligodeoxynecleotides in Colon Adenocarcinoma Cell . . . ”, Cancer Research 51, 2897-2901, Jun. 1, 1991. |
Williams et al., “Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles”, Chemical Reviews, vol. 90, No. 4, Jun. 1990. |
Tidd D., “A Potential Role for Antisense Oligonucleotide Analogues in the Development of Oncogene Targeted Cancer Chemotherapy”, Anticancer Research 10: 1169-1182 (1990). |
Dolnick B., “Antisense Agents in Pharmacology”, Biochemical Pharmacology, vol. 40, No. 4, pp. 671-675, 1990. |
Crooke S., “Therapeutic Applications of Oligonucleotides”, Annu. Rev. Pharmacol. Toxical. 1992, 32:329-76 1992. |
Marasco et al., “Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 signle-chain antibody”, Proc. Natl. Acad. Sci. USA vol. 90, pp. 7889-7893, Aug. 1993. |
Marasco WA, “Intrabodies: tuning the humoral immune system outside in for intracellular immunization”, Gene Therapy (1997) 4, 11-15, 1997. |
Turek F., “Circadian Rhythms”, Horm Res 1998; 49:109-113. |
Schibler U., “New cogwheels in the clockworks”, Nature, vol. 393, pp. 620-621, 1998. |
Higgins et al., “Using CLUSTAL for Multiple Sequence Alignments”, Methods in Enzymology, vol. 266, pp. 383-402, 1996. |
Doan et al., “Antisense Oligonucleotides as Potential Antiviral and Anticancer Agents”, Bull. Cancer, 76 (1989) 849-852. |